Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag FDA pilots real-time clinical trial data monitoring to accelerate drug approvals.

flag The FDA is launching a pilot program to monitor clinical trial data in real time, aiming to accelerate drug approvals. flag The agency will receive aggregated safety and efficacy signals from AstraZeneca and Amgen without accessing raw patient records. flag This initiative seeks to reduce development delays by allowing continuous oversight, though safety remains the top priority.

6 Articles